Haselmayer, Philipp <br/><br/>
A mouse model of systemic lupus erythematosus responds better to soluble TACI than to soluble BAFFR, correlating with depletion of plasma cells.  [electronic resource] 

 -  European journal of immunology  06 2017 
 - 1075-1085 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-4141 
<br/><br/><label>Standard No.: </label>10.1002/eji.201746934  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Autoantibodies--biosynthesis<br/>Autoimmunity<br/>B-Cell Activating Factor--antagonists & inhibitors<br/>B-Cell Activation Factor Receptor--administration & dosage<br/>B-Lymphocytes--immunology<br/>Disease Models, Animal<br/>Flow Cytometry<br/>Kidney--immunology<br/>Lupus Erythematosus, Systemic--immunology<br/>Mice<br/>Plasma Cells--immunology<br/>Transmembrane Activator and CAML Interactor Protein--administration & dosage<br/>Tumor Necrosis Factor Ligand Superfamily Member 13--antagonists & inhibitors